Nobleo Technology and Mach Technology were inspired by specialists of the Emma Kinderziekenhuis to collaborate in developing a smart ‘breathalyzer’.
Chronic infection and inflammation of the airways play a major role in the life of patients with cystic fibrosis (CF; taaislijmziekte) and primary ciliary dyskinesia (PCD; verstoorde functie van de trilhaartjes). The Amsterdam UMC, in collaboration with the Emma children’s hospital & Stichting Steun Emma Kinderziekenhuis is investigating whether home monitoring of exhaled air (consisting of volatile organic compounds) enables detection of infections to the airways. For this purpose an instrument is currently under development.
Nobleo integrated it’s software platform onto the device hardware, to be able to read a set of device sensors gathering the measured data. Data is cached locally where a specific developed software adapter ensures the connection with a cloud environment. The flexibility of the platform is supporting necessary changes to the measuring process during a clinical trial period.
With this functional model, a feasibility study will be conducted where patients will test its usability during daily life. Frequently obtained data could lead to better understanding of the development of airway infections. This will also open up new opportunities for doctors to diagnose more accurately and patients to maintain their lung health.
Find out more by watching the video below.